CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Operating cash flow 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$12.9MFY2026 · since FY2024: $23.8M → $12.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $12.9M | -52.7% |
| FY2025 | $27.3M | +14.9% |
| FY2024 | $23.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net incomeCUVL Net marginCUVL Gross profitCUVL Gross marginCUVL Operating incomeCUVL Operating marginCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Total liabilitiesCUVL Shareholders’ equityCUVL overview →